Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic or naturally occurring small molecule belonging to the class of aristolochic acids and derivatives. It is structurally related to other aristolochic acids found in plants of the Aristolochia genus. The molecule features a phenanthrene core with hydroxy, methoxy, nitro substituents and a dioxole ring fused to the structure. It has been identified as an experimental compound with no current approved medical use. Aristolochic acids are known for their nephrotoxic and carcinogenic properties; they act primarily by forming DNA adducts that can lead to mutations and cancer development. This specific derivative may have similar biological activities but is not used therapeutically due to toxicity concerns[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 9-hydroxy-8-methoxy-6-nitro-phenanthrol[3,4-d][1,3]dioxole-5-carboxylic acid.